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Objective. This study aims to examine the relationship of diabetes care processes and patient outcomes with an expanded set of
indicators regarding patient-oriented care delivery, such as treatment satisfaction, the quality of patient-physician relationship,
and a wider range of patient outcomes such as self-management, health behaviour, disease-related burden, and health-related
quality of life (HRQL).Methods. The study population consisted of 486 participants with type 2 diabetes in two population-based
follow-up surveys, conducted in 2003 to 2005 and 2006 to 2008 in Southern Germany. Data were self-reported and questionnaire-
based, including the SF-12 for HRQL. Multiple regression models were used to identify associations between care processes and
outcomes with adjustment for confounders. Results. Frequent medical examinations increased the likelihood of self-monitoring
activities, such as foot care. A positive patient experienced relationship with their physician is associated with higher adherence to
medical recommendations, such as medication intake, and the score of the SF-12 mental component. Participants with diabetes-
related complications reported higher levels of medical examinations andmultiprofessional care.Conclusions. Indicators of patient-
oriented care should become an indispensable part of diabetes clinical practice guidelines with the aim of striving for more effective
support of patients.
1. Introduction
Type 2 diabetes mellitus (T2DM) is a major global chronic
disease with immense and increasing healthcare costs and
a high disease burden. Complications are the main driver
of diabetes care costs [1, 2]. Diabetes and diabetes-related
complications considerably decrease health-related quality of
life (HRQL) [3]. There is an indispensable need to study how
diabetes care can further be improved to limit the disease
burden and costs.
Health care systems attempt to deal with chronic diseases
by standardizing treatment and clinical practice. Important
policy strategies include the development of national clinical
practice guidelines and indicators for the quality of care
[4–7]. A review of observational studies examining the
relationship between guideline-defined diabetes processes
and health outcomes notes that effects are often surprisingly
small and inconsistent [8].
Health care planners are optimistic about the capacity
of patients to take responsibility for their health and the
management of their chronic illness [9, 10]. The promotion
of patients’ involvement in the management of their chronic
disease has become a popular concept and is delineated
in the chronic care model and the patient empowerment
approach [11, 12]. A patient-centered approach to diabetes
care, endorsed as a central aim by the American Diabetes
Association and the European Association for the Study of
Diabetes [13], includes patient education but goes beyond
this to embrace multiprofessional care, care management
activities, and a proactive, respectful communication with
patients. Glasgow et al. and others argue for a broader
inclusion of patient-centered measures in studies of quality
of diabetes care [14–16].
Studies have shown that diabetes care provided along
these lines enhances metabolic control and clinical out-
comes, in particular, when patients engage actively in their
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self-management [17–20]. Accordingly, we would argue that
care delivery based on a partnership model between health
professionals and patients should improve patient com-
mitment to their health behaviour, self-management, and
adherence, which can be conceptualised as patient outcomes.
Striving towards the use of patient-oriented quality of care
indicators, the main limitation is a lack of empirical data
[21]. Few clinical trials include patient-oriented indicators
as primary outcomes [22]. In fact, clinical trials may not
be very suitable for determining the impact of these indica-
tors when implemented in actual practice. Population-based
observational studies can offer both a view close to health care
provision in practice and data on a wide range of structure,
process, and outcome indicators of diabetes care.
Drawing on data from two population-based survey
studies that were conducted in a region in SouthernGermany
from 2003 to 2008 we performed a post hoc analysis to test
whether patients well supported by health professionals (as
indicated by higher levels of care processes such as medical
examinations, diabetes education, andmultiprofessional care
as well as high treatment satisfaction and good quality of the
relationship between patients and physicians) attain higher
levels of health behaviour and self-management and better
adherence as well as less disease-related burden and higher
HRQL.
2. Methods
2.1. Research Design. The study population consisted of 486
participants with T2DM who took part in either of two
follow-up survey studies conducted in 2003–05 (F3) and
2006–08 (F4). F3 was a follow-up cohort study (𝑁 = 3184)
to a 1994-1995 population-based MONICA survey (S3) with
a response rate of 76%. F4 was a follow-up cohort study
(𝑁 = 3080) of the KORA S4 survey conducted in 1999–
2001 with a response rate of 80%. The KORA research
platform (CooperativeResearch in theRegion ofAugsburg) is
a population-based data pool established in 1996 to continue
and expand the MONICA project in Augsburg, a region
with a mixed urban and rural population of about 600,000
inhabitants in the southern part of Germany, about 70 km
west of Munich. Four cross-sectional health surveys (S1 to
S4) have been performed in the city of Augsburg and its
two surrounding counties at five-year intervals from 1984/85
onwards, each drawn as an independent random sample.The
four cross-sectional surveys serve as cohorts for long term
follow-up studies like F3 and F4. Both studies utilize the
sampling in the original surveys, although data may not be
fully representative due to death and loss to follow-up. Study
designs, sampling methods, and data collection have been
described in detail elsewhere [23].
Both surveys included a personal interview, several self-
administered questionnaires (including the SF-12 question-
naire on HRQL), medical examinations, physical measure-
ments, computer assisted documentation of medication dur-
ing the last 7 days (IDOM), and laboratory tests. Data were
collected at the study centre in Augsburg. The analysed data
is based mainly on items from a questionnaire filled in by
participants with diabetes but includes information collected
in the interview (social-demographic data; type and dura-
tion of diabetes; cardiovascular comorbidity, BMI, physical
activity, smoking, and alcohol) and SF-12 questionnaire data.
IDOM data were used for the classification of diabetes
treatment. Data quality was thoroughly checked in both
studies. For the present analysis, only questions with identical
wording and answer choice order were included to ascertain
the validity of the joint analysis of both studies. Both studies
were approved by the Ethics Committee of the Bavarian
Medical Association and by the Bavarian Commissioner for
Data Protection and Privacy. All study participants provided
written consent.
2.2. Participants. Only study participantswith type 2 diabetes
in F3 and F4 were included in our analysis. Diabetes status
and type of diabetes were assessed by a question in the
interview (self-report of a physician-confirmed diagnosis of
diabetes). Negative self-reports were checked with documen-
tation of respective antidiabetes medication (ATC Codes:
A10A and A10B) and corrected, if necessary. In case of
doubt, the primary physician was contacted to confirm the
diagnosis. Of the 𝑛 = 3184 participants of F3, 𝑛 = 259 were
classified as participantswith type 2 diabetes, respectively, 𝑛 =
227 of the 𝑛 = 3080 participants of F4. We excluded 𝑛 = 11
(F3) respective 𝑛 = 8 (F4) participants with self-reported
type 1 diabetes to improve sample homogeneity. The sample
for analysis consists of 486 participants in total, combining
the data of those two surveys to increase sample size for the
analysis. Participants over 75 years of age filled in a shortened
version of the SF-12 in the F3 survey, leading to a higher
number of missing values for HRQL.
2.3. Measurements
2.3.1. Process Parameters. Diabetes care processes are defined
in this study as elements of diabetes care that result from
direct interactions between health professionals and patients.
Processes of diabetes care were assessed with the following
variables: (1) medical examinations and advice, (2) diabetes
education, (3) treatment satisfaction, (4) patient-perceived
quality of patient/physician relationship, and (5) multiprofes-
sional care. Five types of medical examinations (eye exam,
foot exam, HbA1c lab, blood pressure, and protein/urine
testing) and two types of advice given by the physician on
diet and physical exercise were assessed by the percentage
of participants who reported this activity as having been
performed during the last 12 months (yes/no). Diabetes
education was assessed by the number of courses partic-
ipants reported to have attended. Treatment satisfaction
was assessed with a single item: “In total, how satisfied
are you with the diabetes treatment (including treatment
with insulin, tablets and/or diet) you have been receiving in
the past weeks?” Responses from 1 (very dissatisfied) to 7
(very satisfied) were analyzed across the entire range. The
quality of the patient/physician relationship was assessed by
items relating to four different quality aspects: comprehen-
sibility of information, opportunity to ask questions, shared
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decision-making, and psychological support. Responses for
these variables were dichotomized as “excellent, good” versus
“other” to ascertain good discriminatory power. Multipro-
fessional care was assessed by two items asking whether
dieticians and/or podiatrists were involved in the diabetes
care (yes/no) during the past 12 months.
To prepare process parameters for the multivariate
analysis, we added up answers to respective questions in
each group (medical examinations (7 items), quality of
patient/physician relationship (4 items), and multiprofes-
sional care (2 items)), which were identical in wording and
answer format (see Table 5). Diabetes education (number of
classes attended) and treatment satisfaction (range 1–7) were
already available as single values.
Missing values were set to “0” except for missings with
regard to treatment satisfaction, where the samplemean value
of 5 was imputed. We excluded participants with >3 missings
in the variables relating to process parameters to minimize
the need for such imputations in this dataset with its many
missing values (see Table 5) but to retain a workable sample
size for the multivariate analyses.
2.3.2. Outcome Parameters. In this study we perceive self-
management, adherence, and health behaviour as interme-
diate patient outcomes, that is, activities that may result
from care processes providing effective support of patients.
Complications and health-related quality of life are consid-
ered as medium and long term outcome indicators. Taken
together, patient outcomes were assessed with the following
variables: (1) patient self-management, (2) adherence, (3)
health behaviour, (4) diabetes complications, and (5) health-
related quality of life.
Patient self-management was assessed with items re-
garding self-monitoring activities. Participants were asked
whether and how frequently they had self-monitored feet,
weight, blood glucose, and blood pressure within the past 6
months. Each item was dichotomized into “1” for frequencies
of once a month or more and “0” for less. These activities are
included in a validated scale of diabetes self-care activities
(Summary of Diabetes Self Care Activities, SDSCA [24]),
although this scale uses a different design to assess frequency.
Adherence was assessed with self-reported information
on whether participants were following medical advice
regarding medication, physical activity, diet, and foot care (i)
without difficulties, (ii) with some difficulties, or (iii) with
major difficulties. Each item was dichotomized into “1” for a
report of no difficulties and “0” for some ormajor difficulties.
For descriptive analysis, we also compared how many par-
ticipants stated that they had not received recommendations.
The respective answer category reads “does not apply to me”
(Table 5).
For health behaviour, we used self-reported information
on physical activity, smoking, and alcohol consumption and
coded them in accordance with guidelines [25–27]. Physical
activity is dichotomized as “1” (≥2 hr/week regularly inwinter
and summer) versus “0” (<2 hr/week regularly in winter,
summer, or both). Smoking is dichotomized into “1” (never-
smokers and ex-smokers) and “0” (regular and occasional
smokers). Alcohol intake is transformed by using cut-off
values of weekly consumption in gram (“0” = men > 20 g,
women > 10 g; “1” = equal or less) [28].
Diabetes-related burdenwas assessedwith regard to com-
mondiabetes complications and the occurrence of hyper- and
hypoglycaemia. Diabetic complications refer to the clinical
diagnosis (“ever” versus “never”) of retinopathy, poor blood
circulation in legs, peripheral neuropathy, and microalbu-
minuria. The answer “do not know” is treated as missing
value. Two items ask to recall the occurrence of hypoglycemic
and/or hyperglycemic episodes during the past 6 months
(yes versus no). HRQL is assessed with the SF-12, a validated
questionnaire and short form of the SF-36 [29]. Values are
expressed as two scores, the physical health score and mental
health score (PCS and MCS). Both scores range from 0 to
100, with higher values indicating better HRQL. Scores are
calculated using published standard algorithms [30].
All of the above variables are described in Table 5 with
regard to their wording, the number of missing values, and
the coding used for all analyses. Covariates included in
the regression analysis are time of survey, patient age, sex,
educational level (basic education versus higher), diabetes
duration, diabetes treatment type, and comorbidities (history
of stroke/myocardial infarction: yes/no). Treatment type
refers to (1) no antidiabeticmedication, (2) oral hypoglycemic
agents (OHA), and (3) insulin treatment. Age and duration
of diabetes are entered as continuous variables. For sample
description we added information on the BMI (body mass
in kilograms divided by the square of height in units of
meters (kg/m2)), health insurance status (% statutory), and
enrolment in a diabetes type 2 disease management program
(T2DM-DMP).
2.4. Statistical Analysis. Descriptive statistics (percentages,
means (SD)) were generated for sample characteristics and
process and outcome parameters. Sample characteristics are
reported in total and by treatment type. Differences between
the populations of the two survey periods with time of
survey entered as dichotomous variables (F3, F4) were tested
by Student’s t-test for continuous variables and 𝜒2-test for
categorical variables.Multiple logistic regressionmodelswere
used to examine the association between care processes with
patient outcomes, controlling for age, sex, education, treat-
ment type, cardiovascular comorbidities (previous myocar-
dial infarction or stroke), and time of survey participation as
covariates.
Odds ratios (OR) were calculated for binary variables.
For continuous variables, such as quality of life scores,
adjusted mean differences were based on a linear regression
model. P values less than 0.05 are considered as statistically
significant but used in an explanatory sense to retrieve further
hypotheses. Statistical analysis was performed using SAS
version 9.2 [31].
3. Results
3.1. Sample Description. The sociodemographic characteris-
tics of the total sample and of groups divided by treatment
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type, (1) no antidiabetic medication, (2) oral hypoglycemic
agents (OHA), and (3) insulin treatment, are shown in
Table 1. About half of the sample was treated with oral
hypoglycemic agents (OHA) (𝑛 = 259, 53%), with the
remainder equally divided between those on insulin only
and insulin combination treatment (𝑁 = 111, 23%) and
those without antidiabetic medication (𝑁 = 116, 24%).
The average age is 67.3 years and the proportion of female
participants 44%. Average diabetes duration varies across the
groups with different treatment types from 5.6 years in the
group without antidiabetic medication to 16.2 years in the
group with insulin treatment. Cardiovascular comorbidity
and BMI were highest in the group with insulin treatment.
Overall T2DM disease management-enrolment was 20%; it
was lowest in the group with no medication. There were no
differences between the survey periods regarding baseline
variables entered in the regression analyses (Table 4).
3.2. Description of Process and Outcome Parameter. Table 2
shows the frequencies of care processes and patient outcomes
across the sample. Blood pressure testing was the most
frequent (95%) and feet exams the least frequent (50%) of
medical examinations and advice. HbA1c testing at least
once in the past 12 months was reported by 63%. Of the
seven types of medical examinations and advice, participants
received a mean of 4.2 (2.2 SD). Half of the participants
had attended at least one patient education class (51%).
Across all participants, the average participation completed
one diabetes education class (SD 1.8). The mean value for
treatment satisfaction was 5.3 (1.6 SD) on a rating scale from
1 (very dissatisfied) to 7 (very satisfied).
Quality of patient/physician relationship was rated high
across all items. Only psychological support was acknowl-
edged less often as being “good” or “excellent” (78%), com-
pared with the comprehensibility of information (87%), the
opportunity to ask questions (90%), and shared decision-
making (85%). Of the four items, participants rated an aver-
age of 2.9 (SD 1.5) items as “good” or “excellent.” Participants
reported lowuse ofmultiprofessional care: only 24%had used
a podiatrist during the last 12 months, 17% a dietician.
Patient self-management, that is, monthly or more self-
monitoring of blood-pressure, weight, feet, and blood-
glucose, was reported by 65–80% of participants with the
highest percentage for monitoring weight (81%). Differences
between high adherence with respect to medication and
feet care (>80%) and much lower adherence with regard
to physical activity and diet (ca. 40%) were identified. Up
to a quarter of participants stated that they did not receive
respective medical recommendations. Only 14% of partici-
pants reported to engage in regular physical activity of more
than 2 hours per week. However, more than 88% reported not
smoking and 73% moderate/no alcohol consumption.
Disease-related burden was increased for 9% of partici-
pants with diabetic retinopathy, 12% with microalbuminuria,
21% with poor circulation in legs, and 29% with peripheral
neuropathy. More than half of the participants stated to have
experienced episodes of hyper- and hypoglycemia in the last
6 months. Mean HRQL was 41.5 in the physical component
score (PCS-12) and 49.8 in the mental component score
(MCS-12).
3.3. Evaluation of Relationship between Process and Outcome
Parameters. Results of the regression analyses are presented
in Table 3. We excluded𝑁 = 70 participants (14% of the total
sample) because of >3 missing values in variables pertaining
to care processes (F3: 𝑁 = 49; F4: 𝑁 = 21). Most of them
were participants who did not fill in the diabetes-specific
questionnaire (F3: 𝑁 = 34 of 𝑁 = 259; F4: 𝑁 = 11 of
𝑁 = 227).
Associations with patient self-management, health be-
haviour, disease-related burden, and health-related quality
of life were strongest for medical examinations and advice,
diabetes education, and quality of relationship with physician
and less strong for treatment satisfaction and multipro-
fessional care. A higher number of medical examinations
and advice were associated with self-monitoring of blood
pressure (OR 1.18; CI: 1.03, 1.35), feet (OR 1.24; CI: 1.09,
1.42), and blood glucose (OR 1.23; CI: 1.07, 1.42). However,
participants withmoremedical examinations and advice also
reported less frequently that they had no difficulties with
adherence to diet (OR 0.82; CI 0.70; 0.95). Participation
in diabetes education was positively associated with self-
monitoring feet (OR 1.30; CI 1.06, 1.60) and blood glucose
(OR 1.50; CI 1.18, 1.90). Patient-perceived positive quality of
relationship with the physician was most strongly associated
with adherence to medication (OR 1.92; CI: 1.39, 2.64) and
themental component score of HRQL (mean score difference
2.04 CI: 0.95, 3.13). It was less strongly, but still significantly,
associated with adherence to recommendations regarding
diet (OR 1.33; CI: 1.04, 1.71) and feet care (OR 1.33; CI: 1.02;
1.73) as well as self-monitoring of weight (OR 1.26, CI: 1.00;
1.58). Multiprofessional care was positively associated with
self-monitoring of blood glucose (OR 1.63, CI: 1.02, 2.62).
Contrary to our hypothesis, a number of associations
indicated that participants reporting a higher level of care
processes were more likely to report diabetes-related com-
plications, episodes of hyperglycemia, and lower scores in
the mental component of HRQL. Participants who receive
multiprofessional care are less likely to be free of poor
blood circulation in legs (OR 0.54; CI: 0.35, 0.83), peripheral
neuropathy (OR 0.68; CI: 0.47, 0.99), and hyperglycemia (OR
0.61; CI: 0.40; 0.91). The risk of no retinopathy decreases
with more diabetes education (OR 0.75; CI: 0.63; 0.90),
and the physical component HRQL score is lower (mean
score difference: −1.01; CI: −1.76; −0.26). The risk of no
microalbuminuria decreases with a higher mean score in
medical examination and advice (OR 0.79; CI: 0.63; 0.99).
Finally, the only association found for treatment satisfaction
indicates that participants with more treatment satisfaction
are less likely to not have been diagnosed with retinopathy
(OR 0.71; CI: 0.51; 0.98).
To investigate the robustness of our results, sensitivity
analyses were performed. Models were calculated when (1)
adjusting for diabetes duration instead of treatment type, (2)
diabetes treatment in four (insulin only; insulin and OHA;
OHA; no medication) versus three groups (insulin only or
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Women (%) 43.8 45.7 40.5 49.6
Age (mean yrs (SD)) 67.3 (9.2) 67.0 (9.5) 67.1 (9.1) 68.2 (9.0)
Duration of diabetes (mean yrs;
(SD)) 8.7 (8.4) 5.6 (6.8) 6.9 (6.6) 16.2 (9.4)
% in categories
0–4 yrs 39.7 60.3 43.2 9.9
5–9 yrs 26.3 22.4 31.7 18.0
10–19 yrs 22.0 12.1 20.1 36.9
20–29 yrs 8.2 2.6 3.1 26.1
≥30 yrs 3.7 2.6 1.9 9.0
Education (% basic) 73.5 67.2 74.9 76.6
Cardiovascular comorbidity (%)c 17.9 14.7 13.1 32.4
BMI (kg/m2; mean (SD)) 31.2 (5.1) 29.6 (4.4) 31.4 (4.9) 32.6 (5.8)
Health insurance (% statutory) 89.5 89.7 88.8 91.0
Enrolment in T2DM DMP (%)d 20.2 9.5 24.3 21.6
aOHA = oral hypoglycemic agents; bonly insulin 50.4%; insulin and OHA 49.6%.
cPrevious myocardial infarction or stroke; dSelf-reported enrolment in structured disease management programs (T2DM DMP). These programs were not
widely offered at the time of the F3 survey.
insulin and OHA; OHA; no medication), and (3) controlling
for T2DM-DMP enrolment. In each case, the results proved
to be very comparable (results not shown).
4. Discussion and Conclusion
4.1. Discussion. Measuring quality of care requires process
and outcome measures that go beyond specific clinical
interventions to integrate components that are guided by
the patients themselves [14–16, 32]. We have tried to capture
quality of care broadly by relating care processes to patient
outcomes, expanding the set of indicators to include patients’
activities and experiences. Controlling for treatment type,
we aimed at results applicable across all patient groups.
Our findings confirm a close relationship between care
processes and patient outcomes. Following our hypotheses,
frequentmedical examinations increase the likelihood of self-
monitoring activities. Patient-experienced positive relation-
ship with physician is associated with higher adherence to
medical recommendations, for example, medication and the
SF-12 mental component score. Contrary to our expectation,
higher levels of medical examinations and multiprofessional
care did not preclude disease-related burden but were associ-
ated with it.Thismay indicate that patients’ support by health
professionals is being initiated too late and is only intensified
once complications are present. This study, however, used
a cross-sectional design, which introduces problems with
confounding. We have adjusted for cardiovascular comor-
bidity and treatment type, but these adjustments may not
be enough to control for the intensified health care needs of
sicker patients (i.e., those with more complications). Further
research with prospective studies is needed to reevaluate
these findings.
On a descriptive level, our results provide evidence that
the frequency of care processes still falls short in Germany.
With the exception of blood pressure, all medical examina-
tions required to be performed yearly are reported only from
50%–75% of participants. For example, annual eye exams are
recommended for all patients with T2DM, but in our data
only about two thirds of the patients reported receiving one
in the past 12 months. Only 50–60% of participants reported
receiving advice on diet or on physical exercise or ever
participating in patient diabetes education. Similar findings
have been reported by other studies using insurance claim
data [33]. Guidelines recommend that all patients should
receive these types of examinations and advice as well as
patient education [7].
Patient self-monitoring levels as reported in this study
must also be regarded as relatively low level, considering
that 20–30% of patients do not carry out these activities at
least on a monthly basis. However, in the light of diabetes
treatment guidelines which only very generally recommend
that physicians should review health behaviour with each
patient on a regular basis (i.e., at least annually) this may be
explainable [7, 34]. Although self-monitoring of weight was
reported relatively more often compared to the other types
of self-monitoring, adherence to medical recommendations
concerning physical activities and diet was difficult for the
majority of participants. Whilst adherence to most types of
medical recommendations, except recommendations con-
cerning physical activity, is higher when patients perceive the
quality of patient-physician relationship to be good, patients’
self-monitoring is associated with more frequent medical
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Table 2: Descriptive statistics.
Percentage of total (𝑁 = 486)a
Care processes







Advice on physical exercise 56.0
Frequency of medical exams/adviceb (0,7)c 4.2 (2.2)d
Diabetes education (ever) 51.4
Number of education classes (0,15)c 1.0 (1.8)d
Treatment satisfaction (1,7) (last weeks) 5.3 (1.6)d
Quality of patient/physician relationship (past 12 months)
Comprehensibility of information 87.2
Opportunity to ask questions 90.0
Shared decision-making 84.7
Psychological support 77.7
Frequency of positive ratingsb (0,4)c 2.9 (1.5)d
Multiprofessional care (past 12 months)
Dietician 16.6
Podiatrist 24.0
Frequency of multiprofessional care inputb (0,2)c 0.3 (0.6)d
Patient outcomes





Patients’ adherence to physician’s recommendationse
Medication 90.0 (18.2)e
Physical activity 38.9 (28.2)e
Diet 41.5 (18.1)e
Feet care 81.6 (25.3)e
Health behaviour
Physical activity ≥2 hour/week 14.0
Nonsmoking 87.9
Alcohol use p.d. (≤20 g men; ≤10 g women) 72.8
Complications (% ever diagnosed)
Retinopathy 9.0
Poor blood circulation in legs 21.4
Peripheral neuropathy 29.3
Microalbuminuria 12.2
Adverse conditions associated with diabetes (last 6 months)
Hyperglycemia 60.8
Hypoglycemia 51.1
Health-related quality of life SF-12
Physical score (PCS-12) 41.5 (10.2)d
Mental score (MCS-12) 49.8 (11.0)d
amissings are excluded; bsummary variables used in multivariate analysis. Missings are set to “0” or imputed with mean value in the case of treatment
satisfaction; crange (min,max); dmean (SD); epercentage with no difficulties to adhere (percentage stating “does not apply to me”).
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Odds ratio (95% CI) 𝑃 value
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Adj. mean differences (95% CI)
Health-related quality of life
(SF-12)



















𝑁 = 416, excluding𝑁 = 70 with >3 missings in variables measuring care processes (see Table 2).
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Women (%) 46.3 41.0 0.2345
Age (years, mean (SD)) 66.9 (9.5) 67.9 (8.8) 0.2442
Duration of diabetes (in years; mean (SD)) 9.0 (9.1) 8.4 (7.6) 0.3755
% in categories 0.3637
0–4 yrs 39.8 39.7
5–9 yrs 23.6 29.5
10–19 yrs 22.4 21.6
20–29 yrs 9.7 6.6
≥30 yrs 4.6 2.6
Education (% basic) 73.4 73.6 0.9353
Cardiovascular comorbidity (%)b 18.9 16.7 0.5319
BMI (kg/m2, mean (SD)) 31.2 31.3 0.6823
Type of diabetes treatment (%) 13.5 9.3 0.5341
Insulin 11.2 11.5
Insulin and OHA 51.8 55.1
OHA 23.6 24.2
Diet
Health insurance (% statutory) 87.3 92.1 0.0842
Enrollment in T2DM DMP (%)c 13.1 28.2 <0.0001
aValues are presented as percentages; bMCI or stroke; cSelf-reported enrolment; T2DM-DMPs were not widely offered at the time of the F3 survey.
examinations, advice, and diabetes education. In the guide-
lines, self-monitoring of blood glucose should be encouraged
by physicians as deemed suitable for the individual treatment.
Reimbursement of glucose test strips has been cut for OHA-
treated patients with diabetes in 2011 by the federal regulatory
bodies [35]. They were however available at the time of the
study.
Care processes were not associated with any of the three
types of health behaviour which we assessed, that is, physical
activity, smoking, and alcohol consumption. Only about 15%
of participants report regular physical exercise. Participants
do better managing smoking and alcohol consumption, but
approximately 30% report a higher than recommended intake
of alcohol and approximately 10% are smoking. These figures
are consistent with data from a nationwide German health
survey, carried out between 2008 and 2011 [36]. Patient
education must address these issues more thoroughly and
substantially increase its reach. Only half of the participants
in our study state that they have attended diabetes education
classes at least once. Loveman et al. (2008) conclude that
patient educationmust have a clear program at the outset and
be reinforced at additional points of contact and should be
delivered by a team of educators [37]. There need to be more
efforts to monitor age, sex, and socioeconomic differences in
health behaviour to target interventions and evaluate these
kinds of complex interventions.
In our study, we found that a higher patient-perceived
quality of patient-physician relationship is associated with
a higher score for the mental component of health-related
quality of life (MCS-12), roughly equalling the difference in
MCS-12 scores between women with and without diabetes
[38]. This indicates the potential benefits of intensified
patient-oriented care processes for patient outcomes.
The strength of this study is its population-based
approach, providing data regardless of contact tomedical care
providers or membership in a particular sickness insurance
fund. Baseline characteristics of our sample, such as the dis-
tribution across the treatment groups (no medication, OHA,
and insulin), are similar to what has been found for patients
with T2DM in other study samples in Germany [39]. We
have used multiple logistic regression models and adjusted
for important covariables such as education, cardiovascular
comorbidity, and duration of diabetes. Models proved to be
very robust when sensitivity analyses were performed, that
is, when adjusting for diabetes duration instead of treatment
type.
The questionnaire used in this study did not contain
validated scales for the assessment of care processes or self-
management, such as the Patient Assessment of Chronic
Illness Care (PACIC) [40], Diabetes Management Self-
Efficacy Scale (DMSES) [41], Diabetes Treatment Satisfaction
Questionnaire (DTSQ) [42], or SDSCA scale, most of which
are not available in German or have only recently been
translated [24, 43]. We combined the items on medical
examinations, quality of patient-physician relationship, and
multiprofessional care to reduce complexity of the analysis.
This must be regarded as exploratory and calls for further
validation or the use of validated scales in future studies.
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With regard to measuring HRQL, the use of disease-specific
quality of life questionnaires for type 2 diabetes in addition
to generic questionnaires such as the SF-12 is important
to capture the full spectrum of experiences with diabetes,
including the psychological burden of the disease [44].
Some items had a large number of missing values. Thus
the analysis was run on a smaller sample, removing partici-
pants with >3missing values in process or outcome variables.
The assessment of comorbidities and diabetic complications
based on patient-reports may be particularly susceptible to
information and recall bias. However, studies that use insur-
ance data or review physicians’ charts have found comparable
rates of comorbidities anddiabetic complications inGermany
[45, 46]. Recall of medical examinations can also be biased.
A comparison with data from the largest statutory health
insurance fund in Germany shows good agreement with
regard to HbA1c testing (in our data 64%, health insurance
data 69%) but a higher frequency of self-reported eye exams
(in our data 69%, health insurance data 35%) [33]. Other
types ofmedical examinations studied here are not accounted
for in administrative data in way that would be comparable to
our data.
Our data only captured some aspects of quality of care
while others may be added by other studies. Also, classifying
the elements as done in this study is one way to conceptualise
possible associations and there may be others which are
equally valuable. For example, treatment satisfaction can be
regarded as patient outcome, when factors not under control
of the health care system or the health professionals are con-
sidered equally important. Following this, self-monitoring,
adherence, and health behaviours can be treated as care
processes when focusing on the interaction between health
professional and patient to initiate, adopt, and maintain
actions. In this study however, we perceive self-management,
adherence, and health behaviour as intermediate outcomes,
that is, activities that may develop when care processes work
well beforehand.
Overall, our analysis should be regarded as explorative
and qualitative in its approach. Generalizations from this
rather small regional study with mainly self-reported data
should be done carefully and only in the light of additional
data. This study relied mainly on self-reported questionnaire
data with its limitations in validity and reliability. However,
the data offer rich insights on patients’ perceptions of quality
of diabetes care, which are rare and valuable for expanding
our understanding of patient-oriented processes and out-
comes in diabetes care.
4.2. Conclusion. Efforts to improve diabetes care need to go
beyond guidelines to standardizing treatment and clinical
practice and integrate indicators pertaining to higher levels
of patient-oriented care processes and outcomes. Our study
underlines the importance of monitoring and evaluating
diabetes care by drawing on patient-reported indicators for
both processes and outcomes as an indispensable part of
clinical practice.
Our results stress the importance of findingmore effective
strategies to support patients to change health behaviour, in
particular with regard to physical activity. Attention should
be paid to fostering the patient-perceived quality of patient-
physician relationship. Diabetes education must broaden its
reach and scope, for example, in the field of health behaviour.
Rather than programs delivered just once per patient, it must
be remodelled into providing long-term support to maintain
patient engagement [47, 48]. Further research is warranted
to consider how diabetes self-management is associated with
patients’ prioritization of health outcomes and quality of life,
caregiver support as well as costs.
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schränkungen und -ausschlüsse Harn- und Blutzuckertest-
streifen bei Diabetes mellitus Typ 2,” in 1084 A, GBgSV, Ed.,
Bundesministerium für Gesundheit, Berlin, Germany, 2011.
[36] RKI, German Health Interview and Examination Survey for
Adults (DEGS), Robert Koch Institute, Berlin, Germany, 2013,
http://www.degs-studie.de/english/results/basic-reporting.html.
[37] E. Loveman, G. K. Frampton, and A. J. Clegg, “The clinical
effectiveness of diabetes education models for Type 2 diabetes:
14 Journal of Diabetes Research
a systematic review,” Health Technology Assessment, vol. 12, no.
9, pp. 1–116, 2008.
[38] M. Schunk, P. Reitmeir, S. Schipf et al., “Health-related quality
of life in subjects with and without Type 2 diabetes: pooled
analysis of five population-based surveys in Germany,”Diabetic
Medicine, vol. 29, no. 5, pp. 646–653, 2012.
[39] E. Huppertz, L. Pieper, J. Klotsche et al., “Diabetes mellitus
in german primary care: quality of glycaemic control and
subpopulations not well controlled—results of the DETECT
study,” Experimental and Clinical Endocrinology and Diabetes,
vol. 117, no. 1, pp. 6–14, 2009.
[40] R. E. Glasgow, E. H. Wagner, J. Schaefer, L. D. Mahoney, R. J.
Reid, and S. M. Greene, “Development and validation of the
Patient Assessment of Chronic Illness Care (PACIC),” Medical
Care, vol. 43, no. 5, pp. 436–444, 2005.
[41] J. J. van der Bijl, A. van Poelgeest-Eeltink, and L. Shortridge-
Baggett, “The psychometric properties of the diabetes man-
agement self-efficacy scale for patients with type 2 diabetes
mellitus,” Journal of Advanced Nursing, vol. 30, no. 2, pp. 352–
359, 1999.
[42] C. Bradley, “The diabetes treatment satisfaction questionnaire:
DTSQ,” in Handbook of Psychology and Diabetes: A Guide to
PsychologicalMeasurement in Diabetes Research and Practice, C.
Bradley, Ed., pp. 111–132, Harwood Academic Publishers, Chur,
Switzerland, 1994.
[43] K. Goetz, T. Freund, J. Gensichen, A. Miksch, J. Szecsenyi, and
J. Steinhaeuser, “Adaptation and psychometric properties of the
PACIC short form,”TheAmerican Journal ofManaged Care, vol.
18, no. 2, pp. e55–e60, 2012.
[44] J. Speight, M. D. Reaney, and K. D. Barnard, “Not all roads lead
to Rome—a review of quality of life measurement in adults with
diabetes,” Diabetic Medicine, vol. 26, no. 4, pp. 315–327, 2009.
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